An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study

BACKGROUND. Darbepoetin alfa (DA) has been shown to be an effective treatment of anaemia in patients with chronic kidney disease (CKD) not on dialysis (NoD). EXTEND is an observational study assessing the effectiveness of DA administered once biweekly (Q2W) or monthly (QM) in a general CKD-NoD popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Galle, Jan-Christoph, Claes, Kathleen, Kiss, Istvan, Winearls, Christopher G., Herlitz, Hans, Guerin, Alain, Di Giulio, Salvatore, Suranyi, Michael G., Bridges, Ian, Addison, Janet, Farouk, Mourad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363980/
https://www.ncbi.nlm.nih.gov/pubmed/22140136
http://dx.doi.org/10.1093/ndt/gfr677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363980/
https://www.ncbi.nlm.nih.gov/pubmed/22140136
http://dx.doi.org/10.1093/ndt/gfr677

Ejemplares similares